I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Newest

Federal Reserve Data Released: Industrial Output Continues to Decline

On December 17, 2024, the Federal Reserve released data showing that the output value of the US manufacturing, mining, and utilities sectors decreased by 0.1%. The October data was revised downward to a decrease of 0.4%. The growth rate of the manufacturing output value was 0.2%, and the October data was revised downward to a decrease of 0.7%.
State Grid Bortala Power Supply Company: Achieving the Application of Feeder Automation

BORTALA,China,Dec. 19,2024-- On December 18th at 10:15,as the operation and maintenance personnel of the distribution network automation master station of State GridBortala Power Supply Company handed
China Matters' Feature: Beidahuang: Green Development on Black Soil

BEIJING,Dec. 19,2024-- Beidahuang(literally,"Great Northern Wilderness"),once a desolate land,has now become the cornerstone of China\'s food security. This vast expanse of land in Northeast
Hong Kong Screen Legend Chow Yun Fat Hosts Charity Photography Exhibition "Hong Kong‧Morning" at Harbour City, Showcasing 30 Stunning City Photographs

HONG KONG,Dec. 19,2024-- Chow Yun Fat,the renowned Hong Kong film icon,is celebrated not only for his exceptional acting skills and iconic screen presence but also for his deep passion for photograph
GEEKOM's high-performance mini PCs will shine at CES2025

TAIPEI,Dec. 19,2024-- GEEKOM,a Taiwanese tech company famous for making high quality mini PCs,is heading to CES for the second consecutive year in 2025 with an exciting lineup of new products. Known a
Potech Group Expands Global Presence with New Entity Launch in Australia

SYDNEY,Dec. 19,2024-- Potech,a leading provider of cybersecurity and information & technology solutions,is officially launching its new arm in Australia.
China Matters' Feature: Lars Ulrik Thom: Understanding China on Its Own Terms

BEIJING,Dec. 19,2024-- InYangmeizhu Alley that links to the lively and bustling Dashilan,a historical and cultural conservation area in of Beijing,there is a quaint and charming shop called Beijing Po
French antitrust proceedings concluded

STOCKHOLM,Dec. 19,2024-- The French Competition Authority (FCA) has completed the previously communicatedsecond investigation regarding alleged breaches of antitrust rules in France by Electrolux Grou
CGTN: China's 'pearl': How Macao thrives since its return 25 years ago

BEIJING,Dec. 19,2024-- Twenty-five years. That\'s how long it took Macao to place itself among Asia\'s wealthiest cities and the world at large.
Dstny Strengthens Its European UCaaS Leadership with Fourth Consecutive Top Placement on Frost & Sullivan's 2024 Frost Radar™

BRUSSELS,Dec. 19,2024-- Dstny,a leading European provider of cloud-based business communications,has once again secured a top position on the Frost & Sullivan UCaaS Frost Radar™ 2024. This marks

I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

2024-08-27

ROCKVILLE,Md.,Aug. 26,2024 -- I-Mab (NASDAQ: IMAB),a US-based,global,clinical-stage biotech company,exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer,today announced that management will present at the H.C. Wainwright 26th Annual Global Investment Conference on September 10,2024.

H.C. Wainwright 26th Annual Global Investment Conference

Presentation Time

Tuesday,September 10at5:00 PM ET

Presenters

Sean Fu,PhD,Interim Chief Executive Officer (CEO)

Phillip Dennis,MD,Chief Medical Officer (CMO)

Webcast link

Here

Meetings

One-on-one and small group meetings:September 9 – 10,2024

Management

Participants

Sean Fu,Interim CEO

Joe Skelton,Chief Financial Officer (CFO)

Phillip Dennis,CMO

Tyler Ehler,Senior Director,Investor Relations

The webcast will also be available under "Event Calendar" onI-Mab'sIR website

athttps://ir.i-mabbiopharma.com/

For more information,please contact your H.C. Wainwright representative.

About I-Mab

I-Mab (NASDAQ: IMAB) is a US-based,exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville,Maryland. For more information,please visit https://www.i-mabbiopharma.com and follow us on LinkedIn and X.

For more information,please contact:

Tyler Ehler

Senior Director,Investor Relations

IR@imabbio.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

Links

I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Newest